CORC

在结果中检索

CORC

浏览/检索结果: 共22条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO 会议论文
ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01
作者:  Zeng, Xiaofeng;  Wang, Yongfu;  Jiang, Zhenyu;  Zhang, Zhuoli;  He, Lan
收藏  |  浏览/下载：45/0  |  提交时间：2020/01/03
Phase ib study of safety, tolerability and pharmacokinetics of simotinib in patients with advanced non-small cell lung cancer 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Hu, Xingsheng;  Han, Xiaohong;  Zhang, Li;  Ding, Yanhua;  Wang, Hanping
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04
CHARACTERIZATION OF THE PHARMACOKINETICS OF IXAZOMIB IN CHINESE PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN THE CHINA CONTINUATION OF THE TOURMALINE-MM1 STUDY. 会议论文
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017-02-01
作者:  Hanley, M. J.;  Gupta, N.;  Hou, J.;  Xu, Y.;  Jin, J.
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04
Valuable model for clinical trail-System Toxicological Studies on Active Components in derivatives of Lei-Gong-Teng from Traditional Chinese Medicines 会议论文
作者:  Ren J(任进)
收藏  |  浏览/下载：20/0  |  提交时间：2019/01/08
A phase I study for tolerability, safety, and pharmacokinetics of pyrotinib, a novel irreversible HER2 and EGFR inhibitor, in Chinese patients with HER2(+) metastatic breast cancer. 会议论文
作者:  Xu, Binghe;  Ma, Fei;  Chen, Shanshan;  Li, Qiao;  Yang, Fan
收藏  |  浏览/下载：18/0  |  提交时间：2019/01/08
A phase I study for tolerability, safety, and pharmacokinetics of pyrotinib, a novel irreversible HER2 and EGFR inhibitor, in Chinese patients with HER2(+) metastatic breast cancer. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2015-05-20
作者:  Xu, Binghe;  Ma, Fei;  Chen, Shanshan;  Li, Qiao;  Yang, Fan
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/04
Phase I clinical pharmacokinetics, safety and tolerability of simotinib in advanced NSCLC patients with EGFR mutation 会议论文
EUROPEAN JOURNAL OF CANCER, 2015-09-01
作者:  Han, X.;  Li, N.;  Hu, X.;  Song, Y.;  Zhang, Y.
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04
Clinical pharmacokinetics of simotinib, an oral EGFR tyrosine kinase inhibitor, in patients with advanced NSCLC patients. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2015-05-20
作者:  Han, Xiaohong;  Li, Ning;  Hu, Xingsheng;  Song, Yuanyuan;  Zhang, Yan
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/13
PHARMACOKINETICS (PK) OF SUBCUTANEOUS (SC) AZACITIDINE (AZA) IN CHINESE SUBJECTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS) FROMA PHASE II, OPEN-LABEL STUDY. 会议论文
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015-02-01
作者:  Laille, E.;  Xiao, Z.;  Du, X.;  Dong, Q.;  Songer, S.
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13
Phase I clinical trial of pegylated liposomal mitoxantrone plm60-s: Pharmacokinetics, toxicity, and preliminary efficacy. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2014-05-20
作者:  Shi, Yuankai;  Yang, Jianliang;  Gui, Lin;  Liu, Peng;  Han, Xiaohong
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13

©版权所有 ©2017 CSpace - Powered by CSpace